Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

William M. Hilton, Robert Svatek

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)1062-1063
Number of pages2
JournalEuropean Urology
Volume61
Issue number5
DOIs
StatePublished - May 2012

Fingerprint

Urinary Bladder Neoplasms
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Re : Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status. / Hilton, William M.; Svatek, Robert.

In: European Urology, Vol. 61, No. 5, 05.2012, p. 1062-1063.

Research output: Contribution to journalArticle

@article{8aaac0eaed034d82ad8b28c7aa353a92,
title = "Re: Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status",
author = "Hilton, {William M.} and Robert Svatek",
year = "2012",
month = "5",
doi = "10.1016/j.eururo.2012.02.011",
language = "English (US)",
volume = "61",
pages = "1062--1063",
journal = "European Urology",
issn = "0302-2838",
publisher = "Elsevier",
number = "5",

}

TY - JOUR

T1 - Re

T2 - Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status

AU - Hilton, William M.

AU - Svatek, Robert

PY - 2012/5

Y1 - 2012/5

UR - http://www.scopus.com/inward/record.url?scp=84859364047&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84859364047&partnerID=8YFLogxK

U2 - 10.1016/j.eururo.2012.02.011

DO - 10.1016/j.eururo.2012.02.011

M3 - Article

C2 - 22469412

AN - SCOPUS:84859364047

VL - 61

SP - 1062

EP - 1063

JO - European Urology

JF - European Urology

SN - 0302-2838

IS - 5

ER -